Hims & Hers Health (HIMS) Capital Expenditures (2020 - 2026)
Hims & Hers Health (HIMS) posted Capital Expenditures of $29.8 million for Q1 2026, up 357.34% sequentially from -$11.6 million in Q4 2025, and down 46.06% YoY from $55.3 million in Q1 2025.
Hims & Hers Health (HIMS) Capital Expenditures (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Capital Expenditures for 7 years, with the latest figure at $29.8 million in Q1 2026.
- Quarterly Capital Expenditures fell 46.06% year-over-year to $29.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$239000.0 (down 100.43% YoY) and the FY2025 annual result came in at $25.2 million, up 44978.57% from the prior year.
- Capital Expenditures improved to $29.8 million in Q1 2026 per HIMS's latest filing, from -$11.6 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $55.3 million in Q1 2025 and troughed at -$47.4 million in Q2 2025.
- A 5-year average of $4.8 million and a median of $1.3 million in 2023 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2024 and 2025: Capital Expenditures slumped 262.43% in 2024, then soared 117617.02% in 2025.
- Over 5 years, Capital Expenditures stood at -$17000.0 in 2022, then jumped by 61952.94% to $10.5 million in 2023, then plunged by 262.43% to -$17.1 million in 2024, then jumped by 32.1% to -$11.6 million in 2025, then surged by 357.34% to $29.8 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $29.8 million, -$11.6 million, and $28.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Hims & Hers Health | 7.49 Bn | 6.65 Bn | 480.80 Mn | 25.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.93 Mn |
| Jun 30, 2026 | 25.93 Mn |
| Mar 31, 2026 | 29.84 Mn |
| Mar 31, 2026 | 29.84 Mn |
| Dec 31, 2025 | -11.60 Mn |
| Dec 31, 2025 | -11.60 Mn |
| Sep 30, 2025 | 28.88 Mn |
| Sep 30, 2025 | 28.88 Mn |
| Jun 30, 2025 | -47.37 Mn |
| Jun 30, 2025 | -47.37 Mn |
| Mar 31, 2025 | 55.33 Mn |
| Mar 31, 2025 | 55.33 Mn |
| Dec 31, 2024 | -17.08 Mn |
| Dec 31, 2024 | -17.08 Mn |
| Sep 30, 2024 | 17.09 Mn |
| Sep 30, 2024 | 17.09 Mn |
| Mar 31, 2024 | 47,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Dec 31, 2023 | 10.52 Mn |
| Dec 31, 2023 | 10.52 Mn |